Tel: 732-484-9848
Fax: 888-484-5008
Email: [email protected]
   
Building blocks
Intermediates
Bioactive molecules
Product Pathways
All Targets
Anti-infection
Antibody-drug conjugate....
Apoptosis
Autophagy
Biochemical Reagent
Cell Cycle/DNA Damage
Cytoskeleton
Epigenetics
GPCR/G protein
Immunology/Inflammation
JAK/STAT Signaling
MAPK/ERK Pathway
Membrane Transporter/Io....
Metabolic Enzyme/Protease
Neuronal Signaling
NF-κB
Others
PI3K/Akt/mTOR
Protein Tyrosine Kinase....
Stem Cells/Wnt
TGF-beta/Smad
Vitamin D Related
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Infection
Metabolic Disease
Neurological Disease
Others
Inflammation/Immunology
Product Type
All Products
New Products
Featured Products
Home   »   Product Pathways  »  JNK  »  CC-401

Products are for research use only. Not for human use. We do not sell to patients.


CS-1955 CC-401


(CC401;CC 401)
Structure Price and Availability of    CC-401
United States
Size Price Stock
5mg $150 Backordered Inquiry Please send us inquire for the availability about
CS-1955
10mg $270 Backordered
50mg $800 Backordered
100 mg Get quote
200 mg Get quote
 Distributor In Japan:  フナコシ株式会社 www.funakoshi.co.jp    電話番号:81-3-5684-1620   
 FAX番号:81-3-5684-1775
Inquiry for price and availability only. Please place your order via our email or fax.
Contact us for competitive discounts on bulk quantities .
  • Data Sheet
  • Introduction
  • References
  • Related Products

CC-401  M.Wt:  388.47
CC-401  Formula: C22H24N6O
CC-401  Solubility: 10 mM in DMSO
CC-401  Purity: >98%
CC-401  Storage:  Please store the product under the recommended conditions in the Certificate of Analysis.
CAS: 395104-30-0

View current batch:

CC-401 is a second generation ATP-competitive anthrapyrazolone c-Jun N terminal kinase (JNK) inhibitor with potential antineoplastic activity. IC50 value: Target: JNK In vitro: JNK inhibition decreased cytochrome c release, caspase 3 activation (P<0.05), and lipid peroxidation (P<0.05). JNK inhibition also transiently blocked phosphorylation of c-Jun at 60 minutes after reperfusion (P<0.05) without affecting other MAPK signaling, including p-38 and Erk activation [1]. in vivo: In acute disease, CC-401 blocked JNK signaling and reduced proteinuria in the first 24 h. The transient neutrophil influx seen at 3 h of disease was not affected, however. Continued CC-401 treatment suppressed glomerular and tubulointerstitial damage usually seen at 14 days [2]. Administration of CC-401 to rats prior to bilateral renal I/R prevented acute renal failure and largely prevented tubular damage, leucocyte infiltration and upregulation of pro-inflammatory molecules. However, delaying CC-401 treatment until 1 h after reperfusion (after the peak of JNK activation) had no protective effect [3].

JNK  |  
Keywords: buy CC-401 | CC-401 Supplier | purchase CC-401 | CC-401 cost | CC-401 manufacturer | order CC-401 | CC-401 distributor | CC-401 structure,chemscene
buy 395104-30-0 | 395104-30-0 Supplier | purchase 395104-30-0 | 395104-30-0 cost | 395104-30-0 manufacturer | order 395104-30-0 | 395104-30-0 distributor | 395104-30-0 structure,chemscene


CHEMSCENE, LLC
Tel: 732-484-9848
Fax: 888-484-5008
Email:  [email protected]
Address: 11 Deer Park Drive, Suite 102D Monmouth Junction, NJ 08852.
Products are for research use only. Not for human use. We do not sell to patients. Sitemap | Inhibitor © Copyright 2012. All Rights Reserved.